{"id":"https://openalex.org/W2997915063","doi":"https://doi.org/10.14264/uql.2019.973","title":"A pharmacokinetic/pharmacodynamic and clinical outcome evaluation of beta-lactam antibiotic therapeutic drug monitoring in critically ill patients","display_name":"A pharmacokinetic/pharmacodynamic and clinical outcome evaluation of beta-lactam antibiotic therapeutic drug monitoring in critically ill patients","publication_year":2019,"publication_date":"2019-10-25","ids":{"openalex":"https://openalex.org/W2997915063","doi":"https://doi.org/10.14264/uql.2019.973","mag":"2997915063"},"language":"en","primary_location":{"id":"doi:10.14264/uql.2019.973","doi":"https://doi.org/10.14264/uql.2019.973","is_oa":false,"landing_page_url":"https://doi.org/10.14264/uql.2019.973","pdf_url":null,"source":{"id":"https://openalex.org/S7407053192","display_name":"The University of Queensland","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I165143802","host_organization_name":"The University of Queensland","host_organization_lineage":["https://openalex.org/I165143802"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The University of Queensland","raw_type":"dissertation"},"volume":null,"type":"dissertation","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5081755614","display_name":"Gloria Wong","orcid":"https://orcid.org/0000-0001-9241-6174","observed_orcids":["https://orcid.org/0000-0001-9241-6174"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Gloria Wong","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-9241-6174","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5081755614"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11036","display_name":"Antibiotics Pharmacokinetics and Efficacy","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11036","display_name":"Antibiotics Pharmacokinetics and Efficacy","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10897","display_name":"Antibiotic Use and Resistance","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10147","display_name":"Antibiotic Resistance in Bacteria","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2726","display_name":"Microbiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/beta-lactam-antibiotics","display_name":"beta-lactam antibiotics","score":0.878000020980835},{"id":"https://openalex.org/keywords/therapeutic-drug-monitoring","display_name":"therapeutic drug monitoring","score":0.9950000047683716},{"id":"https://openalex.org/keywords/critically-ill-patients","display_name":"critically ill patients","score":0.9580000042915344},{"id":"https://openalex.org/keywords/pharmacokinetics-pharmacodynamics","display_name":"pharmacokinetics/pharmacodynamics","score":0.7789999842643738},{"id":"https://openalex.org/keywords/unbound-drug-concentration","display_name":"unbound drug concentration","score":0.828000009059906},{"id":"https://openalex.org/keywords/protein-binding","display_name":"protein binding","score":0.8420000076293945},{"id":"https://openalex.org/keywords/hypoalbuminemia","display_name":"hypoalbuminemia","score":0.9940000176429749},{"id":"https://openalex.org/keywords/pk-pd-targets","display_name":"PK/PD targets","score":0.6819999814033508},{"id":"https://openalex.org/keywords/bloodstream-infection","display_name":"bloodstream infection","score":0.5709999799728394},{"id":"https://openalex.org/keywords/dose-optimization","display_name":"dose optimization","score":0.574999988079071},{"id":"https://openalex.org/keywords/pharmacokinetic-variability","display_name":"pharmacokinetic variability","score":0.39899998903274536},{"id":"https://openalex.org/keywords/critically-ill-children","display_name":"critically ill children","score":0.31700000166893005},{"id":"https://openalex.org/keywords/sepsis","display_name":"sepsis","score":0.460999995470047},{"id":"https://openalex.org/keywords/antibiotic-dosing-regimens","display_name":"antibiotic dosing regimens","score":0.36000001430511475}],"concepts":[{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.8652548789978027},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7434878349304199},{"id":"https://openalex.org/C111113717","wikidata":"https://www.wikidata.org/wiki/Q725307","display_name":"Pharmacodynamics","level":3,"score":0.6921894550323486},{"id":"https://openalex.org/C2780272996","wikidata":"https://www.wikidata.org/wiki/Q1261151","display_name":"Therapeutic drug monitoring","level":3,"score":0.6482312679290771},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.6166216135025024},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.6121978163719177},{"id":"https://openalex.org/C2991859549","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Critically ill","level":2,"score":0.5829237699508667},{"id":"https://openalex.org/C501593827","wikidata":"https://www.wikidata.org/wiki/Q12187","display_name":"Antibiotics","level":2,"score":0.5274317860603333},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.49967169761657715},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.468924343585968},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.45536181330680847},{"id":"https://openalex.org/C2778617581","wikidata":"https://www.wikidata.org/wiki/Q41873","display_name":"Beta-lactam","level":3,"score":0.42427757382392883},{"id":"https://openalex.org/C2910641391","wikidata":"https://www.wikidata.org/wiki/Q310286","display_name":"Beta-Lactamase Inhibitors","level":3,"score":0.41336822509765625},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.08588564395904541},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.14264/uql.2019.973","doi":"https://doi.org/10.14264/uql.2019.973","is_oa":false,"landing_page_url":"https://doi.org/10.14264/uql.2019.973","pdf_url":null,"source":{"id":"https://openalex.org/S7407053192","display_name":"The University of Queensland","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I165143802","host_organization_name":"The University of Queensland","host_organization_lineage":["https://openalex.org/I165143802"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The University of Queensland","raw_type":"dissertation"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2055787274","https://openalex.org/W2099916537","https://openalex.org/W2887835365","https://openalex.org/W2085150747","https://openalex.org/W7098187427","https://openalex.org/W4384662952","https://openalex.org/W2167943565","https://openalex.org/W4284704207","https://openalex.org/W4391514740","https://openalex.org/W4362469708"],"abstract_inverted_index":{"Disease-processes":[0],"experienced":[1],"by":[2,118,424],"critically":[3,43,104,166,192,217,255,276,327,372,421,458,475],"ill":[4,34,44,193,218,256,277,328,422,476],"patients":[5,219,257,278,329,477],"commonly":[6,224,454],"cause":[7],"unique":[8],"pharmacokinetic":[9],"(PK)":[10],"changes,":[11],"that":[12,18,310,380,407],"may":[13],"result":[14],"in":[15,42,54,63,86,102,191,216,247,254,275,326,341,370,395,419,456,474,564],"drug":[16,79,201,324,487],"concentrations":[17,232,253,271,418,438,442],"are":[19],"either":[20],"sub-therapeutic":[21],"or":[22],"toxic":[23],"when":[24],"dosing":[25,38,87,99,130,189,299],"is":[26,46,115,142,375,402],"based":[27],"on":[28,125,150,168,220,319,387,415,468,560],"PK":[29,53,170],"data":[30,124,149],"obtained":[31],"from":[32,367,445,522],"non-critically":[33],"patients.\u00a0":[35],"Ensuring":[36],"therapeutic":[37],"of":[39,47,59,70,100,109,121,128,161,171,177,185,198,212,223,229,244,269,289,322,334,339,353,360,383,410,429,463,470,505,511,526,552,555],"beta-lactam":[40,110,151,187,231,252,263,270,298,393,417,452,489,514],"antibiotics":[41,340,453],"patient":[45,498,537,543],"increasing":[48],"concern,":[49],"given":[50],"the":[51,68,103,107,126,157,165,169,172,183,196,210,221,242,267,313,317,320,332,357,371,388,420,435,440,457,492,531,553],"difficult-to-predict":[52],"this":[55,60,205,238,302,342,430,556,565],"population,":[56],"frequent":[57],"use":[58],"antibiotic":[61,72,264,354],"class":[62,338],"treating":[64],"severe":[65,368],"infections":[66,282,369],"and":[67,112,132,261,297,330,356,482,499,519,538,550,558],"importance":[69],"optimal":[71,133],"therapy":[73],"for":[74,97,227,301,336,392,450],"reducing":[75],"mortality":[76],"rates.\u00a0":[77],"Therapeutic":[78],"monitoring":[80],"(TDM),":[81],"a":[82,119,186,306,384,411,464,523],"strategy":[83],"frequently":[84],"used":[85,225,391,455],"drugs":[88],"with":[89,138,195,272,279,439,503,542],"complex":[90],"PK,":[91],"has":[92],"demonstrated":[93],"potential":[94,561],"clinical":[95,140,273,520],"advantages":[96],"improving":[98],"beta-lactams":[101],"ill.\u00a0":[105],"However,":[106],"practice":[108],"TDM":[111,152,335,362,394],"dose":[113],"optimisation":[114],"still":[116,143],"limited":[117],"number":[120],"factors.\u00a0":[122],"Large-scale":[123],"adequacy":[127],"current":[129,314],"regimens":[131],"PK/pharmacodynamic":[134],"(PK/PD)":[135],"targets":[136,246,473],"associated":[137,502,541],"maximal":[139],"outcome":[141,274],"limited.\u00a0":[144],"In":[145],"particular,":[146],"currently":[147],"available":[148,348],"have":[153],"not":[154],"adequately":[155],"quantified":[156],"potentially":[158,364],"profound":[159],"impact":[160,211],"hypoalbuminaemia,":[162],"common":[163],"among":[164],"ill,":[167],"pharmacologically":[173],"active":[174],"unbound":[175,200,230,251,416,437,441,486],"concentration":[176,202],"beta-lactams.This":[178],"Thesis":[179,287],"aims":[180],"to":[181,249,351,363,433,496,535],"describe":[182,241,497,536],"application":[184],"TDM-guided":[188,262],"program":[190],"patients,":[194],"utilization":[197],"directly-measured":[199,250],"data.\u00a0":[203],"Specifically,":[204],"work":[206,239],"will":[207,240,283],"first":[208],"characterise":[209],"altered":[213],"protein":[214,447],"binding":[215,448],"accuracy":[222],"methods":[226],"calculation":[228],"(from":[233],"measured":[234,436],"total":[235],"concentrations).\u00a0":[236],"Secondly,":[237],"achievement":[243],"PK/PD":[245,296,472,517],"relation":[248],"receiving":[258],"empiric":[259],"dosed":[260,481],"treatments.\u00a0":[265],"Finally,":[266],"association":[268,512],"blood":[280],"stream":[281],"also":[284,494,533],"be":[285],"characterised.This":[286],"comprises":[288],"seven":[290,451,545],"chapters.":[291],"Chapter":[292],"one":[293],"introduces":[294],"relevant":[295],"concepts":[300],"Thesis.Chapter":[303],"two":[304,425],"includes":[305,546],"published":[307,446],"review":[308],"article":[309,379,406],"systemically":[311],"analyses":[312],"literature":[315],"at":[316],"time":[318],"risk":[321],"inadequate":[323],"exposure":[325],"discusses":[331],"role":[333],"different":[337],"setting.":[343],"This":[344],"chapter":[345],"specifically":[346],"addresses":[347],"evidence":[349],"relating":[350],"practices":[352],"TDM,":[355],"practical":[358],"aspects":[359],"applying":[361],"improve":[365],"outcomes":[366,521],"ill.Chapter":[373],"three":[374],"an":[376,403,547],"original":[377,404],"research":[378,405,563],"reports":[381],"findings":[382,409,462,510,554],"multicentre":[385],"survey":[386],"various":[389],"approaches":[390],"intensive":[396],"care":[397],"units":[398],"(ICUs)":[399],"worldwide.Chapter":[400],"four":[401],"describes":[408,461,509],"single-centre":[412,465],"prospective":[413,466,527],"study":[414,431,467,493,532],"determined":[423],"assays.\u00a0":[426],"The":[427],"aim":[428],"was":[432],"compare":[434],"conventionally":[443],"predicted":[444],"values":[449],"ill.\u00a0Chapter":[459],"five":[460],"attainment":[469,504],"predefined":[471],"who":[478],"received":[479],"empirically":[480],"TDM-guide":[483],"(using":[484],"direct-measured":[485],"concentrations)":[488],"antibiotics.":[490],"Furthermore,":[491,530],"aimed":[495,534],"treatment":[500,539],"factors":[501,540],"target":[506],"concentrations.Chapter":[507],"six":[508],"between":[513],"exposures,":[515],"using":[516],"indices,":[518],"retrospective":[524],"analysis":[525],"studies":[528],"database.\u00a0":[529],"outcome.Chapter":[544],"overall":[548],"discussion":[549],"summary":[551],"Thesis,":[557],"explores":[559],"future":[562],"area.":[566]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2020-01-10T00:00:00"}